COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020)
- PMID: 32517645
- DOI: 10.33321/cdi.2020.44.51
COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020)
Abstract
Confirmed cases in Australia notified up to 24 May 2020: notifications = 7,135; deaths = 102. The incidence of COVID-19 has markedly reduced since a peak in mid-March. There have been no cases reported in SA, the NT or the ACT in the last four weeks. The numbers of new cases reported from other jurisdictions continue to be very low. Testing rates have been higher across all jurisdictions, with Victoria reporting an 85% testing rate increase and NSW a 40% increase over this period. The positivity rate nationally continues to remain very low at less than 0.1% over the reporting period. Continued high rates of testing are necessary to detect and mitigate the spread of COVID-19 in the community. Over the past fortnight, 45% of cases acquired their infection overseas. Of cases considered to be locally acquired over this period, most were associated with contacts of confirmed cases or were associated with known outbreaks. The highest rate of COVID-19 continues to be among people aged 65-79 years. Three-quarters of all cases in this age group have been associated with overseas travel, including several outbreaks linked to cruise ships. The lowest rate of disease is in children under 18, a pattern reflected in international reports. A small proportion of cases overall have experienced severe disease, requiring hospitalisation or intensive care with some fatalities. The crude case fatality rate amongst Australian cases is 1.4%. People who are older and have one or more comorbidities are more likely to experience severe disease. A combination of early case identification, physical distancing, public health measures and a reduction in international travel have likely been effective in slowing the spread of the disease in Australia. In addition, the median number of days between symptom onset and diagnostic testing has improved considerably from 7 days in the early phase of the outbreak to 1 day in the latest phase of the epidemic. Internationally, as at 24 May 2020, there have been recent increases in the number of daily cases reported globally. The largest numbers of both cases and deaths have been reported in the United States. Of the confirmed cases reported globally, the case fatality rate is approximately 6.5%. Countries in South America are starting to see rapid acceleration, while the United States is seeing a very slow decline in its daily new case numbers. In the South East Asia region, India and Bangladesh are seeing accelerating epidemics, compounded by the recovery from Cyclone Amphan. Increasing numbers of cases are also being reported in Africa, although the numbers are much smaller. In the Pacific there are very few daily new cases reported.
Keywords: 2019-nCoV; Australia; COVID-19; SARS-CoV-2; acute respiratory disease; coronavirus disease 2019; epidemiology; novel coronavirus.
© Commonwealth of Australia CC BY-NC-ND.
Similar articles
-
COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).Commun Dis Intell (2018). 2020 Jun 17;44. doi: 10.33321/cdi.2020.44.52. Commun Dis Intell (2018). 2020. PMID: 32552623
-
COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).Commun Dis Intell (2018). 2020 May 22;44. doi: 10.33321/cdi.2020.44.45. Commun Dis Intell (2018). 2020. PMID: 32522141
-
COVID-19, Australia: Epidemiology Report 19 (Fortnightly reporting period ending 21 June 2020).Commun Dis Intell (2018). 2020 Jun 29;44. doi: 10.33321/cdi.2020.44.54. Commun Dis Intell (2018). 2020. PMID: 32600222
-
COVID-19 Australia: Epidemiology Report 28: Fortnightly reporting period ending 25 October 2020.Commun Dis Intell (2018). 2020 Oct 4;44. doi: 10.33321/cdi.2020.44.84. Commun Dis Intell (2018). 2020. PMID: 33143597 Review.
-
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1. Pediatr Pulmonol. 2020. PMID: 32483934 Free PMC article. Review.
Cited by
-
Rapid Large-Scale COVID-19 Testing During Shortages.Diagnostics (Basel). 2020 Jul 8;10(7):464. doi: 10.3390/diagnostics10070464. Diagnostics (Basel). 2020. PMID: 32650631 Free PMC article.
-
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.Mult Scler Relat Disord. 2020 Nov;46:102516. doi: 10.1016/j.msard.2020.102516. Epub 2020 Sep 16. Mult Scler Relat Disord. 2020. PMID: 32957057 Free PMC article.
-
Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.BMC Infect Dis. 2020 Aug 6;20(1):584. doi: 10.1186/s12879-020-05314-x. BMC Infect Dis. 2020. PMID: 32762665 Free PMC article.
-
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.Open Forum Infect Dis. 2022 Jan 31;9(3):ofac002. doi: 10.1093/ofid/ofac002. eCollection 2022 Mar. Open Forum Infect Dis. 2022. PMID: 35169588 Free PMC article.
-
A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.Elife. 2023 Jan 20;12:e78089. doi: 10.7554/eLife.78089. Elife. 2023. PMID: 36661303 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous